Provista Diagnostics to Present at The 18th Annual BIO CEO & Investor Conference
08 févr. 2016 11h31 HE
|
Provista Diagnostics, Inc.
New York, NY, Feb. 08, 2016 (GLOBE NEWSWIRE) -- NEW YORK, NY – February 8, 2016 – Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will...
Provista Diagnostics to Present at The 18th Annual BIO CEO & Investor Conference
08 févr. 2016 10h48 HE
|
Provista Diagnostics, Inc.
New York, NY, Feb. 08, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will deliver a corporate overview at the...
Provista Diagnostics to Present at the 2015 Canaccord Genuity Medical Technology & Diagnostics Forum
18 nov. 2015 16h19 HE
|
Provista Diagnostics, Inc.
New York, NY, Nov. 18, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will deliver a corporate overview at the...
Provista Diagnostics Offers Hope for the Early Detection of Breast Cancer in Women with Dense Breasts
29 sept. 2015 15h52 HE
|
Provista Diagnostics, Inc.
NEW YORK, NY, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc. today announced that the data from two prospective, randomized, multi-center clinical studies, evaluating a novel...
Provista Diagnostics to Present New Clinical Data at the 2015 American Society of Clinical Oncology Breast Cancer Symposium
23 sept. 2015 14h00 HE
|
Provista Diagnostics, Inc.
NEW YORK, NY, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing a new generation of proprietary...
Provista Diagnostics Announces Reelection of the Company's Board of Directors
21 sept. 2015 14h04 HE
|
Provista Diagnostics, Inc.
NEW YORK, NY, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company developing and commercializing a new generation of proprietary blood-based...
Provista Diagnostics Announces the Closing of $6.0 Million Financing
04 août 2015 15h20 HE
|
Provista Diagnostics, Inc.
NEW YORK, NY, Aug. 4, 2015 (GLOBE NEWSWIRE) -- August 4, 2015: Provista Diagnostics, Inc., a privately held molecular diagnostics company headquartered in New York, today announced the closing of $6.0...
Provista Diagnostics, Inc. published Late-Breaking Publication only Abstract in conjunction with the 2015 ASCO Annual Meeting
03 juin 2015 15h31 HE
|
Provista Diagnostics, Inc.
NEW YORK, NY, June 3, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc. today announced that they published
an Abstract, in conjunction with the 2015 ASCO Annual Meeting held
May 29 - June 2th, 2015...
Provista Diagnostics to Present at Leerink Global Healthcare Conference
09 févr. 2015 09h00 HE
|
Provista Diagnostics, Inc.
New York, NY, Feb. 9, 2015 (GLOBE NEWSWIRE) -- NEW YORK, NY - February 9, 2015: Provista
Diagnostics, Inc., a privately-held molecular diagnostics company
focused on developing and...
Provista Diagnostics to Present Data From a Prospective Clinical Trial at the 2014 San Antonio Breast Cancer Symposium
10 déc. 2014 10h19 HE
|
Provista Diagnostics, Inc.
NEW YORK, Dec. 10, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing a new generation of proprietary...